EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Response to “Refining FIB-4-based risk stratification in adverse drug reactions”

Joana Henze, Lennard Goette, Harald Dormann, Carolin V Schneider, Corinna Meeßen, Anja Knüppel-Ruppert, Andrea Kriegisch-Stumpf, Matthias Schwab, Julia C Stingl, Katja S Just

European Journal of Clinical Pharmacology · 2026-07 · 82 (7)

DOI: 10.1007/s00228-026-04101-y ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 17.06.2026. Verfasst von Joana Henze und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology, University Hospital RWTH Aachen, Wendlingweg 2, D-52074, Aachen, Germany. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum RWTH Aachen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Institute of Clinical Pharmacology, University Hospital RWTH Aachen, Wendlingweg 2, D-52074, Aachen, Germany.
  • Emergency Department, Klinikum Fürth, Fürth, Germany.
  • Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Central Emergency Department, Hospital Ingolstadt, Ingolstadt, Germany.
  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Department of Clinical Pharmacology, and Pharmacy and Biochemistry, University Tübingen, Tübingen, Germany.

Förderung

  • Universitätsklinikum RWTH Aachen

Zitieren

APA

Henze, J., Goette, L., Dormann, H., Schneider, C. V., Meeßen, C., Knüppel-Ruppert, A., Kriegisch-Stumpf, A., Schwab, M., Stingl, J. C., & Just, K. S. (2026). Response to “Refining FIB-4-based risk stratification in adverse drug reactions”. European Journal of Clinical Pharmacology, 82(7). https://doi.org/10.1007/s00228-026-04101-y

Vancouver

Henze J, Goette L, Dormann H, Schneider CV, Meeßen C, Knüppel-Ruppert A, et al. Response to “Refining FIB-4-based risk stratification in adverse drug reactions”. European Journal of Clinical Pharmacology. 2026;82(7). doi:10.1007/s00228-026-04101-y

BibTeX
@article{Henze2026,
  author = {Henze, Joana and Goette, Lennard and Dormann, Harald and Schneider, Carolin V and Meeßen, Corinna and Knüppel-Ruppert, Anja and Kriegisch-Stumpf, Andrea and Schwab, Matthias and Stingl, Julia C and Just, Katja S},
  title = {Response to “Refining FIB-4-based risk stratification in adverse drug reactions”},
  journal = {European Journal of Clinical Pharmacology},
  year = {2026},
  volume = {82},
  number = {7},
  doi = {10.1007/s00228-026-04101-y}
}
Kostenlos starten →